Abstract
In the presence of KF as base and THF as solvent, the tandem Michael addition-elimination reaction of different 5-alkoxy-3,4-dihalo-2(5H)-furanones with aminomethyl benzimidazoles at room temperature gave 21 target compounds simultaneously containing both bioactive benzimidazole and 2(5H)-furanone moieties in yields of 62-88 % (mostly over 71 %). The structures of all the newly synthesized compounds were elucidated and confirmed by FTIR, UV, 1H NMR, 13C NMR, mass spectroscopy and elemental analysis. The simple one-pot synthetic method provides a brief route for the introduction of the benzimidazole unit into 2(5H)-furanone derivatives under mild conditions without any metal catalysts. This transformation also affords an important synthetic strategy for the series 2(5H)-furanone derivatives, as well as a basis for the activity test of these potential drug molecules.
Keywords: Benzimidazole, bioactive units, combination, Csp2-N bond formation, 2(5H)-furanone, metal-free catalysis, Michael addition-elimination reaction, one-pot synthesis.
Letters in Organic Chemistry
Title:One-Pot Synthesis of 5-Alkoxy-4-amino-3-halo-2(5H)-furanones Containing Benzimidazole Moiety in the Absence of Metal Catalyst
Volume: 12 Issue: 5
Author(s): Pai Peng, Min-Hua Feng, Jie Shi, Jia-Li Zheng, Yan-Cheng Wu, Zhao-Yang Wang and Ren-Hong Chen
Affiliation:
Keywords: Benzimidazole, bioactive units, combination, Csp2-N bond formation, 2(5H)-furanone, metal-free catalysis, Michael addition-elimination reaction, one-pot synthesis.
Abstract: In the presence of KF as base and THF as solvent, the tandem Michael addition-elimination reaction of different 5-alkoxy-3,4-dihalo-2(5H)-furanones with aminomethyl benzimidazoles at room temperature gave 21 target compounds simultaneously containing both bioactive benzimidazole and 2(5H)-furanone moieties in yields of 62-88 % (mostly over 71 %). The structures of all the newly synthesized compounds were elucidated and confirmed by FTIR, UV, 1H NMR, 13C NMR, mass spectroscopy and elemental analysis. The simple one-pot synthetic method provides a brief route for the introduction of the benzimidazole unit into 2(5H)-furanone derivatives under mild conditions without any metal catalysts. This transformation also affords an important synthetic strategy for the series 2(5H)-furanone derivatives, as well as a basis for the activity test of these potential drug molecules.
Export Options
About this article
Cite this article as:
Peng Pai, Feng Min-Hua, Shi Jie, Zheng Jia-Li, Wu Yan-Cheng, Wang Zhao-Yang and Chen Ren-Hong, One-Pot Synthesis of 5-Alkoxy-4-amino-3-halo-2(5H)-furanones Containing Benzimidazole Moiety in the Absence of Metal Catalyst, Letters in Organic Chemistry 2015; 12 (5) . https://dx.doi.org/10.2174/1570178612666150305002655
DOI https://dx.doi.org/10.2174/1570178612666150305002655 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natural Polyphenols in the Treatment of Alzheimer’s Disease
Current Drug Targets The Use of the Zebrafish Model to Aid in Drug Discovery and Target Validation
Current Topics in Medicinal Chemistry Phosphotyrosine Phosphatases in Cancer Diagnostic and Treatment
Recent Patents on DNA & Gene Sequences Lymphocyte Biomarkers of Clinical Responses to Adoptive Immunotherapy of Malignant Melanoma
Current Cancer Therapy Reviews Anti-Inflammatory Effects of Different Drugs/Agents with Antioxidant Property on Endothelial Expression of Adhesion Molecules
Cardiovascular & Hematological Disorders-Drug Targets Preface [Hot Topic: Therapeutic Manipulation of the Immune System: Old and New Therapeutic Approaches (Executive Editor : Emilio Jirillo)]
Current Pharmaceutical Design Vitamin D in Chronic Kidney Disease: New Potential for Intervention
Current Drug Targets Galectin-1 is a Novel Factor that Regulates Myotube Growth in Regenerating Skeletal Muscles
Current Drug Targets HIV Protease Inhibitors Impact on Apoptosis
Medicinal Chemistry Omentin: Linking Metabolic Syndrome and Cardiovascular Disease
Current Vascular Pharmacology Regeneration of Pancreatic β-Cells in vivo as a Potential Therapeutic Approach for Diabetes Mellitus
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Rodent Models of Persistent Pain in Drug Discovery and Development
Current Pharmaceutical Biotechnology The Dynamic TRPA1 Channel: A Suitable Pharmacological Pain Target?
Current Pharmaceutical Biotechnology Non-Peptidic Small-Molecule Antagonists of the Human Platelet Thrombin Receptor PAR-1
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Effects of Low Doses of Polyunsaturated Fatty Acids on the Attention Deficit/Hyperactivity Disorder of Children: A Systematic Review
Current Neuropharmacology Stem Cells in Adult Human Ovaries: From Female Fertility to Ovarian Cancer
Current Pharmaceutical Design Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells
Current Cancer Drug Targets Association Study of IL-4 -590 C/T and DDX39B -22 G/C Polymorphisms with the Risk of Late-Onset Alzheimer’s Disease in Iranian Population
Current Aging Science N-Glycosylation of Plant-produced Recombinant Proteins
Current Pharmaceutical Design STAT3 as a Central Regulator of Tumor Metastases
Current Molecular Medicine